Patents Represented by Attorney David J. Aston
  • Patent number: 6472155
    Abstract: PCR (polymerase chain reaction) primers for the detection of certain Bacillus species, such as Bacillus anthracis. The primers specifically amplify only DNA found in the target species and can distinguish closely related species. Species-specific PCR primers for Bacillus anthracis, Bacillus globigii and Clostridium perfringens are disclosed. The primers are directed to unique sequences within sasp (small acid soluble protein) genes.
    Type: Grant
    Filed: June 8, 2000
    Date of Patent: October 29, 2002
    Assignee: The Regents of the University of California
    Inventor: Nancy McKinney
  • Patent number: 6409648
    Abstract: The present invention provides a novel telomere associated protein (Trf1-interacting nuclear protein 2 “Tin2”) that hinders the binding of Trf1 to its specific telomere repeat sequence and mediates the formation of a Tin2-Trf1-telomeric DNA complex that limits telomerase access to the telomere. Also included are the corresponding nucleic acids that encode the Tin2 of the present invention, as well as mutants of Tin2. Methods of making, purifying and using Tin2 of the present invention are described. In addition, drug screening assays to identify drugs that mimic and/or complement the effect of Tin2 are presented.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: June 25, 2002
    Assignee: The Regents of the University of California
    Inventors: Judith Campisi, Sahn-Ho Kim
  • Patent number: 6379472
    Abstract: The present invention comprises growing gallium nitride films in the presence of bismuth using MBE at temperatures of about 1000 K or less. The present invention further comprises the gallium nitride films fabricated using the inventive fabrication method. The inventive films may be doped with magnesium or other dopants. The gallium nitride films were grown on sapphire substrates using a hollow anode Constricted Glow Discharge nitrogen plasma source. When bismuth was used as a surfactant, two-dimensional gallium nitride crystal sizes ranging between 10 &mgr;m and 20 &mgr;m were observed. This is 20 to 40 times larger than crystal sizes observed when GaN films were grown under similar circumstances but without bismuth. It is thought that the observed increase in crystal size is due bismuth inducing an increased surface diffusion coefficient for gallium. The calculated value of 4.7×10−7 cm2/sec. reveals a virtual substrate temperature of 1258 K which is 260 degrees higher than the actual one.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: April 30, 2002
    Assignee: The Regents of the University of California
    Inventors: Christian K. Kisielowski, Michael Rubin
  • Patent number: 6299897
    Abstract: This invention provides compositions for inhibiting the binding between two cells, one expressing P- or L-selectin on the surface and the other expressing the corresponding ligand. A covalently crosslinked lipid composition is prepared having saccharides and acidic group on separate lipids. The composition is then interposed between the cells so as to inhibit binding. Inhibition can be achieved at an effective oligosaccharide concentration as low as 106 fold below that of the free saccharide. Since selectins are involved in recruiting cells to sites of injury, these composition scan be used to palliate certain inflammatory and immunological conditions.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: October 9, 2001
    Assignee: The Regents of the University of California
    Inventors: Jon O. Nagy, Wayne R. Spevak, Falguni Dasgupta, Caroline Bertozzi
  • Patent number: 6287790
    Abstract: The localization of nuclear apparatus proteins (NUMA) is used to identify tumor cells and different stages in the tumor progression and differentiation processes. There is a characteristic organization of NuMA in tumor cells and in phenotypically normal cells. NuMA distribution patterns are significantly less diffuse in proliferating non-malignant cells compared to malignant cells. The technique encompasses cell immunostaining using a NuMA specific antibody, and microscopic analysis of NuMA distribution within each nucleus.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: September 11, 2001
    Assignee: The Regents of the University of California
    Inventors: Sophie Lelièvre, Mina Bissell
  • Patent number: 6250848
    Abstract: Disclosed are processes for monitoring and control of underground contamination, which involve the application of ferrofluids. Two broad uses of ferrofluids are described: (1) to control liquid movement by the application of strong external magnetic fields; and (2) to image liquids by standard geophysical methods.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: June 26, 2001
    Assignee: The Regents of the University of California
    Inventors: George J. Moridis, Curtis M. Oldenburg
  • Patent number: 6123941
    Abstract: A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying .beta..sub.1 integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: September 26, 2000
    Assignee: The Regents of the University of California
    Inventors: Mina J. Bissell, Valerie M. Weaver
  • Patent number: 6100033
    Abstract: A a diagnostic test useful for prenatal identification of Down syndrome and mental retardation. A method for gene therapy for correction and treatment of Down syndrome. DYRK gene involved in the ability to learn. A method for diagnosing Down's syndrome and mental retardation and an assay therefor. A pharmaceutical composition for treatment of Down's syndrome mental retardation.
    Type: Grant
    Filed: April 30, 1998
    Date of Patent: August 8, 2000
    Assignee: The Regents of the University of California
    Inventors: Desmond J. Smith, Edward M. Rubin
  • Patent number: 6091798
    Abstract: An apparatus and method for focusing X-rays. In one embodiment, his invention is a commercial-grade compound refractive X-ray lens. The commercial-grade compound refractive X-ray lens includes a volume of low-Z material. The volume of low-Z material has a first surface which is adapted to receive X-rays of commercially-applicable power emitted from a commercial-grade X-ray source. The volume of low-Z material also has a second surface from which emerge the X-rays of commercially-applicable power which were received at the first surface. Additionally, the commercial-grade compound refractive X-ray lens includes a plurality of openings which are disposed between the first surface and the second surface. The plurality of openings are oriented such that the X-rays of commercially-applicable power which are received at the first surface, pass through the volume of low-Z material and through the plurality openings. In so doing, the X-rays which emerge from the second surface are refracted to a focal point.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: July 18, 2000
    Assignee: The Regents of the University of California
    Inventors: David R. Nygren, Robert Cahn, Bjorn Cederstrom, Mats Danielsson, Jonas Vestlund
  • Patent number: 6040188
    Abstract: The present invention relates to measurements of contaminants in the soil and other organic or environmental materials, using a biologically relevant chemical analysis that will measure the amount of contaminants in a given sample that may be expected to be absorbed by a human being ingesting the contaminated soil. According to the present invention, environmental samples to be tested are added to a pre-prepared physiological composition of bile salts and lipids. They are thoroughly mixed and then the resulting mixture is separated e.g. by centrifugation. The supernatant is then analyzed for the presence of contaminants and these concentrations are compared to the level of contaminants in the untreated samples. It is important that the bile salts and lipids be thoroughly pre-mixed to form micelles.
    Type: Grant
    Filed: November 18, 1998
    Date of Patent: March 21, 2000
    Assignee: The Regents of the University of California
    Inventor: Hoi-Ying N. Holman
  • Patent number: 6025585
    Abstract: The invention comprises a combination of a low resistivity, or electrically conducting, silicon layer that is transparent to long or short wavelength photons and is attached to the backside of a photon-sensitive layer of silicon, such as a silicon wafer or chip. The window is applied to photon sensitive silicon devices such as photodiodes, charge-coupled devices, active pixel sensors, low-energy x-ray sensors and other radiation detectors. The silicon window is applied to the back side of a photosensitive silicon wafer or chip so that photons can illuminate the device from the backside without interference from the circuit printed on the frontside. A voltage sufficient to fully deplete the high-resistivity photosensitive silicon volume of charge carriers is applied between the low-resistivity back window and the front, patterned, side of the device. This allows photon-induced charge created at the backside to reach the front side of the device and to be processed by any circuitry attached to the front side.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: February 15, 2000
    Assignee: The Regents of the University of California
    Inventor: Stephen Edward Holland
  • Patent number: 6004436
    Abstract: A process is described to modify the chemical structure of an aerogel under conditions which inhibit plasma formation within the aerogel pores, which process includes; (a) providing an aerogel with a pore size of less than 0.1.mu.; (b) exposing the initial aerogel to at least one gas selected from the group consisting of reducing gas, oxidizing gas, noble gas and combinations thereof, with the proviso that at least one reducing gas or one oxidizing gas is present; and (c) irradiating the combination of step (b) while maintaining the temperature to preserve the structural composition of the aerogel at a pressure of between about 0.1 and 54 Torr for between and about 5 and 960 minutes. This process produces a modified aerogel wherein the pore size does not allow for plasma formation within the pore. Chemical reactions occur within the pores of the aerogel of a nonplasma nature. These modified aerogels have a number of uses, including catalysts, ceramics, composites, chemical sensors, LED's and the like.
    Type: Grant
    Filed: August 16, 1996
    Date of Patent: December 21, 1999
    Assignee: The Regents of the University of California
    Inventor: Michael Ayers
  • Patent number: 5985852
    Abstract: This invention provides compositions for inhibiting the binding between two cells, one expressing P- or L-selectin on the surface and the other expressing the corresponding ligand. A covalently crosslinked lipid composition is prepared having saccharides and acidic group on separate lipids. The composition is then interposed between the cells so as to inhibit binding. Inhibition can be achieved at an effective oligosaccharide concentration as low as 10.sup.6 fold below that of the free saccharide. Since selectins are involved in recruiting cells to sites of injury, these composition scan be used to palliate certain inflammatory and immunological conditions.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: November 16, 1999
    Assignee: The Regents of the University of California
    Inventors: Jon O. Nagy, Wayne R. Spevak, Falguni Dasgupta, Caroline Bertozzi
  • Patent number: 5925229
    Abstract: A variable rate density gradient electrophoric gel is described which separate LDL subfractions with the precision of ultracentrifugation techniques. Also, an innovative bottom inlet mixing chamber particularly useful for producing these gels is described.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: July 20, 1999
    Assignee: The Regents of the University of California
    Inventors: Ronald M. Krauss, Patricia J. Blanche, Joseph Orr
  • Patent number: 5916710
    Abstract: A solid state secondary battery utilizing a low cost, environmentally sound, sodium cobalt bronze electrode. A method is provided for producing same.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: June 29, 1999
    Assignee: The Regents of The University of California
    Inventors: Marca M. Doeff, Yanping Ma, Steven J. Visco, Lutgard DeJonghe
  • Patent number: 5882436
    Abstract: The inventive material exhibits giant magnetoresistance upon application of an external magnetic field at room temperature. The hysteresis is minimal. The inventive material has a magnetic phase formed by eutectic decomposition. The bulk material comprises a plurality of regions characterized by a) the presence of magnetic lamellae wherein the lamellae are separated by a distance smaller than the mean free path of the conduction electrons, and b) a matrix composition having nonmagnetic properties that is interposed between the lamellae within the regions. The inventive, rapidly quenched, eutectic alloys form microstructure lamellae having antiparallel antiferromagnetic coupling and give rise to GMR properties. The inventive materials made according to the inventive process yielded commercially acceptable quantities and timeframes. Annealing destroyed the microstructure lamellae and the GMR effect. Noneutectic alloys did not exhibit the antiparallel microstructure lamellae and did not possess GMR properties.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: March 16, 1999
    Assignee: The Regents of the University of California
    Inventors: Johannes J. Bernardi, Gareth Thomas, Andreas R. Huetten
  • Patent number: 5880461
    Abstract: A novel optical position sensor is described that uses two component photodiodes electrically connected in parallel, with opposing polarities. A lens provides optical gain and restricts the acceptance angle of the detector. The response of the device to displacements of an optical spot is similar to that of a conventional bi-cell type position sensitive detector. However, the component photodiode design enables simpler electronic amplification with inherently less electrical noise than the bi-cell. Measurements by the sensor of the pointing noise of a focused helium-neon laser as a function of frequency demonstrate high sensitivity and suitability for optical probe beam deflection experiments.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: March 9, 1999
    Assignee: The Regents of The University of California
    Inventor: Jonathan David Spear
  • Patent number: 5879744
    Abstract: Disclosed herewith is a process of forming an aerogel composite which comprises introducing a gaseous material into a formed aerogel monolith or powder, and causing decomposition of said gaseous material in said aerogel in amounts sufficient to cause deposition of the decomposition products of the gas on the surfaces of the pores of the said aerogel.
    Type: Grant
    Filed: August 8, 1997
    Date of Patent: March 9, 1999
    Assignee: The Regents of the University of California
    Inventors: Wanqing Cao, Arlon Jason Hunt
  • Patent number: 5880466
    Abstract: The design and operation of a new type of charged-particle trap provides simultaneous measurements of mass, charge, and velocity of large electrospray ions. The trap consists of a detector tube mounted between two sets of center-bored trapping plates. Voltages applied to the trapping plates define symmetrically-opposing potential valleys which guide axially-injected ions to cycle back and forth through the charge-detection tube. A low noise charge-sensitive amplifier, connected to the tube, reproduces the image charge of individual ions as they pass through the detector tube. Ion mass is calculated from measurement of ion charge and velocity following each passage through the detector.
    Type: Grant
    Filed: June 2, 1997
    Date of Patent: March 9, 1999
    Assignee: The Regents of the University of California
    Inventor: W. Henry Benner
  • Patent number: 5177191
    Abstract: Highly purified antihemophilic factor can be produced from a cryoprecipitate by a process comprising a PEG precipitation step, a viral inactivation step and a gel filtration step, all steps being carried out at room temperature.
    Type: Grant
    Filed: September 24, 1990
    Date of Patent: January 5, 1993
    Assignee: Miles, Inc.
    Inventors: William J. Brockway, Richard L. Seng